Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -86,161 | -90,192 | -62,790 | -47,380 | -37,467 |
| Depreciation Amortization | 673 | 516 | 738 | 1,464 | 1,933 |
| Accounts receivable | N/A | N/A | N/A | 116 | -116 |
| Accounts payable and accrued liabilities | -3,450 | 928 | 2,194 | 1,542 | -2,032 |
| Other Working Capital | -868 | 6,235 | 4,595 | -4,738 | -6,713 |
| Other Operating Activity | 10,881 | 5,102 | 1,128 | 1,696 | 6,196 |
| Operating Cash Flow | $-78,925 | $-77,411 | $-54,135 | $-47,300 | $-38,199 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,693 | -23,884 | -9,438 | 10,019 | -19,666 |
| PPE Investments | -144 | -769 | -505 | -690 | -136 |
| Investing Cash Flow | $-8,837 | $-24,653 | $-9,943 | $9,329 | $-19,802 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 13,500 | 0 | 2,000 | 15,000 |
| Debt Repayment | -9,492 | -2,630 | -4,246 | -579 | -1,834 |
| Common Stock Issued | 94,788 | 58,172 | 119,793 | 35,315 | 31,990 |
| Common Stock Repurchased | N/A | N/A | -32 | N/A | 0 |
| Financing Cash Flow | $85,296 | $69,042 | $115,515 | $36,736 | $45,156 |
| Beginning Cash Position | 48,490 | 81,512 | 30,075 | 31,310 | 44,155 |
| End Cash Position | 46,024 | 48,490 | 81,512 | 30,075 | 31,310 |
| Net Cash Flow | $-2,466 | $-33,022 | $51,437 | $-1,235 | $-12,845 |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,925 | -77,411 | -54,135 | -47,300 | -38,199 |
| Capital Expenditure | -144 | -769 | -505 | -690 | -136 |
| Free Cash Flow | -79,069 | -78,180 | -54,640 | -47,990 | -38,335 |